1. Home
  2. DERM vs HNNA Comparison

DERM vs HNNA Comparison

Compare DERM & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DERM
  • HNNA
  • Stock Information
  • Founded
  • DERM 2014
  • HNNA 1989
  • Country
  • DERM United States
  • HNNA United States
  • Employees
  • DERM N/A
  • HNNA N/A
  • Industry
  • DERM Biotechnology: Pharmaceutical Preparations
  • HNNA Investment Managers
  • Sector
  • DERM Health Care
  • HNNA Finance
  • Exchange
  • DERM Nasdaq
  • HNNA Nasdaq
  • Market Cap
  • DERM 95.0M
  • HNNA 94.7M
  • IPO Year
  • DERM 2021
  • HNNA N/A
  • Fundamental
  • Price
  • DERM $5.19
  • HNNA $12.10
  • Analyst Decision
  • DERM Strong Buy
  • HNNA
  • Analyst Count
  • DERM 3
  • HNNA 0
  • Target Price
  • DERM $9.50
  • HNNA N/A
  • AVG Volume (30 Days)
  • DERM 55.0K
  • HNNA 6.6K
  • Earning Date
  • DERM 03-20-2025
  • HNNA 02-13-2025
  • Dividend Yield
  • DERM N/A
  • HNNA 4.54%
  • EPS Growth
  • DERM N/A
  • HNNA 75.66
  • EPS
  • DERM N/A
  • HNNA 1.12
  • Revenue
  • DERM $57,771,000.00
  • HNNA $33,210,000.00
  • Revenue This Year
  • DERM N/A
  • HNNA N/A
  • Revenue Next Year
  • DERM $36.49
  • HNNA N/A
  • P/E Ratio
  • DERM N/A
  • HNNA $10.80
  • Revenue Growth
  • DERM N/A
  • HNNA 38.27
  • 52 Week Low
  • DERM $2.85
  • HNNA $6.60
  • 52 Week High
  • DERM $6.89
  • HNNA $13.88
  • Technical
  • Relative Strength Index (RSI)
  • DERM 60.26
  • HNNA 47.38
  • Support Level
  • DERM $4.85
  • HNNA $11.97
  • Resistance Level
  • DERM $5.37
  • HNNA $13.12
  • Average True Range (ATR)
  • DERM 0.40
  • HNNA 0.45
  • MACD
  • DERM 0.02
  • HNNA -0.03
  • Stochastic Oscillator
  • DERM 70.49
  • HNNA 26.62

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

About HNNA Hennessy Advisors Inc.

Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.

Share on Social Networks: